LanzaTech to Form New Joint Venture and Launch Spin-Out of LanzaX Business, and Appoints Interim CFO of LanzaTech
Provided By GlobeNewswire
Last update: Jan 22, 2025
Announces intent to spin out and form a growth-oriented joint venture for LanzaX, the Company’s differentiated synthetic biology platform, with Tharsis Capital joining as new LanzaX strategic partner to accelerate financing for the synbio development pipeline
Read more at globenewswire.comNASDAQ:LNZAW (3/3/2025, 4:30:00 PM)
0.17
0 (0%)
0.6801
-0.12 (-14.87%)
Find more stocks in the Stock Screener
LNZAW Latest News and Analysis
18 days ago - ChartmillKeep an eye on the top gainers and losers in Thursday's session.Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
18 days ago - ChartmillWhich stocks are moving on Thursday?Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
